Detalles de la búsqueda
1.
A Rare Case of Bladder Metastasis From Endometrial Cancer Treated With Robot-Assisted Radical Cystectomy.
Cureus;
16(5): e59713, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38841040
2.
Prognostic outcomes in Japanese patients with metastatic castration-sensitive prostate cancer: Comparative assessments between conventional androgen deprivation therapy (ADT) and ADT with novel androgen receptor signal inhibitor.
Int J Urol;
2024 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38764245
3.
Impact of Robotic-Assisted Partial Nephrectomy with Single Layer versus Double Layer Renorrhaphy on Postoperative Renal Function.
Curr Oncol;
31(5): 2758-2768, 2024 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38785490
4.
Discrepancy in the Location of Prostate Cancer Indicated on Biparametric Magnetic Resonance Imaging and Pathologically Diagnosed Using Surgical Specimens.
Curr Oncol;
31(5): 2846-2855, 2024 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38785497
5.
Efficacy and safety of combination neoadjuvant chemo-hormonal therapy and robot-assisted radical prostatectomy for oligometastatic prostate cancer.
Int J Urol;
2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38454625
6.
Recombinant antithrombin attenuates acute kidney injury associated with rhabdomyolysis: an in vivo animal study.
Intensive Care Med Exp;
12(1): 7, 2024 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38282162
7.
Comparison of perioperative outcomes and complications between intracorporeal, extracorporeal, and hybrid ileal conduit urinary diversion during robot-assisted radical cystectomy: a comparative propensity score-matched analysis from nationwide multi-institutional study in Japan.
Int J Clin Oncol;
29(1): 64-71, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37864612
8.
The Geriatric Nutritional Risk Index Predicts Prognosis in Japanese Patients with LATITUDE High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Multi-Center Study.
Cancers (Basel);
15(22)2023 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001593
9.
Temporary Tumor Shrinkage Following Enfortumab Vedotin Therapy for Metastatic Urothelial Carcinoma After Radical Cystectomy With Neoadjuvant Chemotherapy: A Case Report.
Cureus;
15(8): e42954, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37667727
10.
Prognostic Factors for Resolution Delay of Lower Urinary Tract Symptoms in Patients with Prostate Cancer after Low-Dose-Rate Brachytherapy.
Cancers (Basel);
15(16)2023 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37627078
11.
Utility and safety of robot-assisted radical cystectomy in older patients with bladder cancer.
Minim Invasive Ther Allied Technol;
32(6): 307-313, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37607213
12.
Perilesional Targeted Biopsy Combined with MRI-TRUS Image Fusion-Guided Targeted Prostate Biopsy: An Analysis According to PI-RADS Scores.
Diagnostics (Basel);
13(15)2023 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568971
13.
Biochemical recurrence after chemohormonal therapy followed by robot-assisted radical prostatectomy in very-high-risk prostate cancer patients.
J Robot Surg;
17(5): 2441-2449, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37466903
14.
Chronological Changes of Lower Urinary Tract Symptoms in Elderly Patients with Prostate Cancer after Low-Dose-Rate Prostate Brachytherapy.
Life (Basel);
13(7)2023 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37511882
15.
Case of extragonadal germ cell tumor mimicking left adrenal tumor.
Urol Case Rep;
50: 102477, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37416752
16.
Efficacy and Safety of First-Line Cytokines versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study.
Cancers (Basel);
15(10)2023 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37345082
17.
[A Case of Refractory Lymphatic Leakage after Robot-Assisted Radical Cystectomy].
Hinyokika Kiyo;
69(5): 137-142, 2023 May.
Artículo
en Japonés
| MEDLINE | ID: mdl-37312494
18.
Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience.
Curr Oncol;
30(6): 5680-5689, 2023 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37366909
19.
Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer.
Life (Basel);
13(5)2023 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37240717
20.
Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence.
Diagnostics (Basel);
13(9)2023 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37175052